Hitachi

PSS, which develops tools for the IVD space, will supply to Hitachi its nucleic acid isolation system, fully automated diagnostic instruments, and reagents.

Under the terms of the collaboration, the firms will combine ZS Genetics' proprietary technologies with HTA's experience in high-resolution electron microscopy.

Initial projects include developing new automation systems based on PCR and next-generation sequencing.

Du Pont has been awarded

NEW YORK (GenomeWeb) − One challenge developers of nanopore sequencing technologies have been facing is DNA passing through the pores too quickly to detect its sequence with single-base resolution.

NEW YORK (GenomeWeb) – Annai Systems said today that it is working with Hitachi Data Systems to provide an integrated data management and analysis system that combines Hitachi's high-performance compute and cloud-based solutions and the Annai-GNOS data management software platform.

Title: Method for reconstructing evolutionary data
US Patent Number: 8,645,074
Assignee: International Business Machines

Title: Methods and compositions for base calling nucleic acids
US Patent Number: 8,612,161

NEW YORK (GenomeWeb News) – A group of bioinformatics and technology-focused firms and institutes that challenges informatics researchers to solve specific problems, has issued a new challenge to spur investigators to develop better methods for identifying cancer-associated mutations.

Hitachi High-Technologies has been awarded US Patent No. 8,574,891, "Nucleic acid analyzer, automatic analyzer, and analysis method."
Kohshi Maeda, Masato Ishizawa, Minoru Sano, and Hironori Kaji are named as inventors.

Pages

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.